SARS-CoV-2 Spike protein (S1, His Tag, CHO-expressed)
| $380.00 | |
| Z03515-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $380.00 | |
| Z03515-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | SARS-CoV-2 | ||||
| Protein Construction |
|
||||
| Purity | > 95% as analyzed by SDS-PAGE | ||||
| Endotoxin Level | < 0.2 EU/μg of protein by gel clotting method | ||||
| Biological Activity | SARS-CoV-2 Spike protein (S1, His Tag, CHO-expressed) can bind with Human ACE2 (Cat. No.: Z03484) in functional ELISA assay. | ||||
| Expression System | CHO | ||||
| Theoretical Molecular Weight | 79 kDa | ||||
| Formulation | Supplied as a solution in PBS pH 7.4 | ||||
| Concentration | Please refer to the COA for the specific lot. | ||||
| Storage & Stability | Upon receiving, this product remains stable for 6 months at -20°C or below. Avoid repeated freeze-thaw cycles. |
»
»
Immobilized ACE-2 Fc Chimera, Human (Cat. No. Z03484) at 2 μg/mL can bind SARS-CoV-2 Spike protein (S1, His Tag, CHO-expressed) (Cat. No. Z03515) with a serial dilution.
THETM His Tag Antibody [HRP], mAb, Mouse (Cat.No.A00612) is used as a secondary antibody (0.2 μg/mL).
»
Lane 1: 1μg of SARS-CoV-2 Spike protein (S1, His Tag, CHO-expressed), reducing(R)
> 95% as analyzed by SDS-PAGE
»
| Target Background | SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. S protein plays an important role in the induction of neutralizing antibodies and T-cell responses, as well as protective immunity. |
| Synonyms | SARS-CoV-2 S1 protein; 2019-nCoV S1 protein |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.